APA (7th ed.) Citation

Tian, Y., Yang, W., Xu, J., Li, Y., Tang, W., & Xu, C. (2025). Risk and prognosis of second primary malignancies in patients with follicular lymphoma in the era of rituximab: A population study based on the SEER database. PLoS ONE, 20(5), 1. https://doi.org/10.1371/journal.pone.0324532

Chicago Style (17th ed.) Citation

Tian, Ying, Wanxi Yang, Juan Xu, Yuanxiao Li, Wenjiao Tang, and Caigang Xu. "Risk and Prognosis of Second Primary Malignancies in Patients with Follicular Lymphoma in the Era of Rituximab: A Population Study Based on the SEER Database." PLoS ONE 20, no. 5 (2025): 1. https://doi.org/10.1371/journal.pone.0324532.

MLA (9th ed.) Citation

Tian, Ying, et al. "Risk and Prognosis of Second Primary Malignancies in Patients with Follicular Lymphoma in the Era of Rituximab: A Population Study Based on the SEER Database." PLoS ONE, vol. 20, no. 5, 2025, p. 1, https://doi.org/10.1371/journal.pone.0324532.